Asher Bio Biotech
Funding, team structure (meet the founders), partners and clients
Market - Biotech
Location - San Francisco, USA
Description - At Asher Biotherapeutics, we are pioneering a new approach with our cis‑targeted immunotherapies. Our immunotherapies selectively activate only the immune cell types that drive the desired therapeutic response. With this innovation, we address an inherent shortcoming of conventional immunotherapies, which indiscriminately act on multiple cell types, resulting in suboptimal efficacy and side effects.
Team
Founder Ivana Djuretic
Funding
Asher Bio raised $55,000,000 with Third Rock Ventures and Boxer Capital of Tavistock Group and Invus, Y Combinator, MBC Biolabs - 3/23/2021